NO donors-relaxation is impaired in aorta from hypertensive rats due to a reduced involvement of K(+) channels and sarcoplasmic reticulum Ca(2+)-ATPase

Life Sci. 2011 Oct 24;89(17-18):595-602. doi: 10.1016/j.lfs.2011.07.022. Epub 2011 Aug 3.

Abstract

Aims: To examine the vasodilatation induce by the NO donors, [Ru(terpy)(bdq)NO](3+) (TERPY) and sodium nitroprusside (SNP), and to compare their effects in aortic rings from hypertensive 2K-1C and normotensive 2K rats.

Main methods: Vascular reactivity was performed in aortic rings pre-contracted with phenylephrine (Phe 100nM). We have analyzed the maximal relaxation (Emax) and potency (pD(2)) of NO donors.

Key findings: Potency of SNP was greater than TERPY in both arterial groups. The vasodilatation induced by TERPY was greater in 2K than in 2K-1C, and it was inhibited by sGC inhibitor ODQ in 2K and in 2K-1C aortic rings. ODQ did not alter the efficacy to SNP, but it reduced its potency in 2K and 2K-1C. The blockade of K(+) channels reduced the potency of TERPY only in aortic rings of 2K. On the other hand, the potency of SNP was reduced in both 2K and 2K-1C. The combination of ODQ and TEA reduced the relaxation induced by TERPY and SNP in 2K and reduced the efficacy to SNP in 2K-1C aortic rings but it had no additional effect on the TERPY relaxation in 2K-1C aortas. The production of cGMP induced by TERPY was greater than that produced by SNP, which was similarly increased in 2K and 2K-1C. Sarcoplasmic reticulum Ca-ATPase inhibition only impaired the relaxation induced by SNP in 2K aortic rings.

Significance: Taken together, our results provide evidences that in this model of hypertension, impaired K(+) channels activation by TERPY and SERCA activation by SNP may contribute to decreased vasodilatation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Aorta / drug effects
  • Aorta / physiopathology
  • Cyclic GMP / metabolism
  • Guanylate Cyclase / antagonists & inhibitors
  • Hypertension / physiopathology*
  • Hypertension, Renal / physiopathology
  • Male
  • Nitric Oxide Donors / pharmacology*
  • Nitroprusside / pharmacology*
  • Organometallic Compounds / pharmacology*
  • Potassium Channel Blockers / pharmacology
  • Potassium Channels / metabolism*
  • Rats
  • Rats, Wistar
  • Ruthenium / pharmacology*
  • Sarcoplasmic Reticulum Calcium-Transporting ATPases / antagonists & inhibitors
  • Sarcoplasmic Reticulum Calcium-Transporting ATPases / metabolism*
  • Vasodilation / drug effects*

Substances

  • Nitric Oxide Donors
  • Organometallic Compounds
  • Potassium Channel Blockers
  • Potassium Channels
  • Nitroprusside
  • Ruthenium
  • Sarcoplasmic Reticulum Calcium-Transporting ATPases
  • Guanylate Cyclase
  • Cyclic GMP